{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:15:53Z","timestamp":1786119353427,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1097\/mbc.0b013e32832f6c40","type":"journal-article","created":{"date-parts":[[2009,9,29]],"date-time":"2009-09-29T03:14:48Z","timestamp":1254194088000},"page":"601-604","source":"Crossref","is-referenced-by-count":2,"title":["Successful use of recombinant factor VIIa in a preterm infant with life-threatening haematuria"],"prefix":"10.1097","volume":"20","author":[{"given":"Kirstin","family":"Faust","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birthe","family":"Tr\u00f6ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fritz","family":"Kahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"G\u00f6pel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"H\u00e4rtel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20-20210203","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.pcl.2004.03.006","article-title":"Differential diagnosis and management of anemia in the newborn.","volume":"51","author":"Bizzarro","year":"2004","journal-title":"Pediatr Clin North Am"},{"issue":"Suppl 1","key":"R2-20-20210203","first-page":"S61","article-title":"Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII","volume":"9","author":"Hoffman","year":"1998","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R3-20-20210203","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/09537100802406653","article-title":"Understanding the therapeutic action of recombinant factor VIIa in platelet disorders","volume":"19","author":"Hers","year":"2008","journal-title":"Platelets"},{"key":"R4-20-20210203","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/pbc.21375","article-title":"A comprehensive review of rFVIIa use in a tertiary care pediatric center","volume":"50","author":"Heller","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R5-20-20210203","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/08880010802016904","article-title":"Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder","volume":"25","author":"Yilmaz","year":"2008","journal-title":"Pediatr Hematol Oncol"},{"key":"R6-20-20210203","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/1076029607302402","article-title":"Evaluation of off-label recombinant activated factor VII for multiple indications in children","volume":"13","author":"Reiter","year":"2007","journal-title":"Clin Appl Thromb Hemost"},{"key":"R7-20-20210203","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMoa0707534","article-title":"Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage","volume":"358","author":"Mayer","year":"2008","journal-title":"N Engl J Med"},{"key":"R8-20-20210203","first-page":"644","article-title":"Consensus recommendations for the off-label use of recombinant human factor VIIa (NovoSeven\u00ae) therapy","volume":"30","author":"Shander","year":"2005","journal-title":"Pharma Ther"},{"key":"R9-20-20210203","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/MPH.0b013e3180335bcb","article-title":"Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases","volume":"29","author":"Mitsiakos","year":"2007","journal-title":"J Pediatr Hematol Oncol"},{"key":"R10-20-20210203","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/01.mbc.0000220245.20036.2d","article-title":"The use of recombinant activated factor VII in the treatment of massive pulmonary hemorrhage in a preterm infant","volume":"17","author":"Cetin","year":"2006","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R11-20-20210203","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/sj.jp.7210787","article-title":"Treatment of severe pulmonary hemorrhage with activated recombinant factor VII (rFVIIa) in very low birth weight infants","volume":"22","author":"Olomu","year":"2002","journal-title":"J Perinatol"},{"key":"R12-20-20210203","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s00134-002-1489-x","article-title":"Life-threatening hemorrhage in neonates: management with recombinant activated factor VII","volume":"28","author":"Veldman","year":"2002","journal-title":"Intensive Care Med"},{"key":"R13-20-20210203","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1080\/14767050701411935","article-title":"Use of recombinant factor VIIa in a preterm infant with coagulopathy and subdural hematoma","volume":"20","author":"Altuncu","year":"2007","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R14-20-20210203","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/pbc.20078","article-title":"Management of coagulopathy with recombinant factor VIIa in a neonate with echovirus type 7","volume":"43","author":"Tancabelic","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"R15-20-20210203","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/sj.jp.7211588","article-title":"Recombinant activated factor seven in acute life-threatening bleeding in neonates: report on three cases and review of literature","volume":"26","author":"Hunseler","year":"2006","journal-title":"J Perinatol"},{"key":"R16-20-20210203","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1542\/peds.110.1.169","article-title":"The use of recombinant activated factor VII to control bleeding in a preterm infant undergoing exploratory laparotomy","volume":"110","author":"Chuansumrit","year":"2002","journal-title":"Pediatrics"},{"key":"R17-20-20210203","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1440-1754.2008.01446.x","article-title":"Traumatic bleeding at birth treated with Factor VII","volume":"45","author":"Carmo","year":"2009","journal-title":"J Paediatr Child Health"},{"key":"R18-20-20210203","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/MPH.0b013e3181639b28","article-title":"Recombinant activated factor VII as a hemostatic agent in very low birth weight preterms with gastrointestinal hemorrhage and disseminated intravascular coagulation","volume":"30","author":"Fischer","year":"2008","journal-title":"J Pediatr Hematol Oncol"},{"key":"R19-20-20210203","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.jpedsurg.2006.05.054","article-title":"Recombinant factor VIIa for treatment of massive liver fracture in a premature infant","volume":"41","author":"Abdullah","year":"2006","journal-title":"J Pediatr Surg"},{"key":"R20-20-20210203","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jpeds.2005.07.034","article-title":"Spontaneous liver hemorrhage during laparotomy for necrotizing enterocolitis: a potential role for recombinant factor VIIa","volume":"147","author":"Filan","year":"2005","journal-title":"J Pediatr"},{"key":"R21-20-20210203","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s00431-003-1369-6","article-title":"Refractory bleeding following major surgery of a giant sacrococcygeal teratoma in a premature infant: successful use of recombinant factor VIIa","volume":"163","author":"Girisch","year":"2004","journal-title":"Eur J Pediatr"},{"key":"R22-20-20210203","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/sj.jp.7211086","article-title":"Use of recombinant factor VIIa in infants with severe coagulopathy","volume":"24","author":"Fontaine","year":"2004","journal-title":"J Perinatol"},{"key":"R23-20-20210203","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00001721-200301000-00021","article-title":"Recombinant factor VIIa in preterm neonates with prolonged prothrombin time","volume":"14","author":"Greisen","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R24-20-20210203","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/01.PCC.0000185491.17584.4B","article-title":"A prospective pilot study of prophylactic treatment of preterm neonates with recombinant activated factor VII during the first 72 h of life","volume":"7","author":"Veldman","year":"2006","journal-title":"Pediatr Crit Care Med"},{"key":"R25-20-20210203","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1213\/01.ANE.0000173666.80578.49","article-title":"Use of recombinant factor VIIa (Novoseven) in combination with other coagulation products led to a thrombotic occlusion of the truncus brachiocephalicus in a neonate supported by extracorporal membrane oxygenation","volume":"101","author":"Velik-Salchner","year":"2005","journal-title":"Anesth Analg"},{"key":"R26-20-20210203","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1460-9592.2007.02328.x","article-title":"rFVIIa in the treatment of persistent hemorrhage in pediatric patients on ECMO following surgery for congenital heart disease","volume":"17","author":"Veldman","year":"2007","journal-title":"Paediatr Anaesth"},{"key":"R27-20-20210203","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.athoracsur.2007.02.051","article-title":"Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery","volume":"84","author":"Agarwal","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"R28-20-20210203","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1460-9592.2008.02905.x","article-title":"Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass","volume":"19","author":"Guzzetta","year":"2009","journal-title":"Paediatr Anaesth"},{"key":"R29-20-20210203","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00043426-199021000-00019","article-title":"Development of the hemostatic system in the neonate and young infant","volume":"12","author":"Andrew","year":"1990","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"R30-20-20210203","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1182\/blood.V88.3.900.900","article-title":"Evolution of blood coagulation activators and inhibitors in the healthy human fetus","volume":"88","author":"Reverdiau-Moalic","year":"1996","journal-title":"Blood"},{"key":"R31-20-20210203","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0378-3782(84)90035-5","article-title":"\u2018Normal\u2019 haemostasis parameters: a study in a well defined inborn population of preterm infants","volume":"9","author":"Beverley","year":"1984","journal-title":"Early Hum Dev"},{"key":"R32-20-20210203","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1182\/blood.V72.5.1651.1651","article-title":"Development of the human coagulation system in the healthy premature infant","volume":"72","author":"Andrew","year":"1988","journal-title":"Blood"},{"key":"R33-20-20210203","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1365-2141.2002.03674.x","article-title":"The investigation and management of neonatal haemostasis and thrombosis","volume":"119","author":"Williams","year":"2002","journal-title":"Br J Haematol"},{"key":"R34-20-20210203","doi-asserted-by":"crossref","first-page":"F319","DOI":"10.1136\/fn.88.4.F319","article-title":"Effects of gestational age and prenatal and perinatal events on the coagulation status in premature infants","volume":"88","author":"Salonvaara","year":"2003","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R35-20-20210203","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/j.1651-2227.1997.tb14816.x","article-title":"Coagulation and fibrinolytic systems in the ill preterm newborn","volume":"86","author":"Mautone","year":"1997","journal-title":"Acta Paediatr"},{"key":"R36-20-20210203","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/MBC.0b013e3283104093","article-title":"Mechanisms of action of recombinant activated factor VII in the context of tissue factor concentration and distribution","volume":"19","author":"Ovanesov","year":"2008","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R37-20-20210203","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1182\/blood-2008-02-139113","article-title":"The glycoprotein Ib-IX-V complex contributes to tissue factor-independent thrombin generation by recombinant factor VIIa on the activated platelet surface","volume":"112","author":"Weeterings","year":"2008","journal-title":"Blood"}],"container-title":["Blood Coagulation & Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MBC.0b013e32832f6c40","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:05:54Z","timestamp":1786039554000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001721-200910000-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e32832f6c40","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}